000			02055 a2200565 4500
005			20250513145752.0
264		0	_c19980820
008			199808s 0 0 eng d
022			_a0019-9567
024	7		_a10.1128/IAI.66.8.3510-3518.1998 _2doi
040			_aNLM _beng _cNLM
100	1		_aJames, S L
245	0	0	_aInducible nitric oxide synthase-deficient mice develop enhanced type 1 cytokine-associated cellular and humoral immune responses after vaccination with attenuated Schistosoma mansoni cercariae but display partially reduced resistance. _h[electronic resource]
260			_bInfection and immunity _cAug 1998
300			_a3510-8 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aAntibodies, Protozoan _ximmunology
650	0	4	_aAntibody Formation
650	0	4	_aCells, Cultured
650	0	4	_aCytokines _xbiosynthesis
650	0	4	_aFemale
650	0	4	_aImmunity, Cellular
650	0	4	_aImmunity, Innate
650	0	4	_aInterferon-gamma _xbiosynthesis
650	0	4	_aInterleukin-4 _xbiosynthesis
650	0	4	_aInterleukin-5 _xbiosynthesis
650	0	4	_aLipopolysaccharides _xpharmacology
650	0	4	_aLung _ximmunology
650	0	4	_aMacrophages, Peritoneal _ximmunology
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aMitogens _xpharmacology
650	0	4	_aNitric Oxide Synthase _xdeficiency
650	0	4	_aNitric Oxide Synthase Type II
650	0	4	_aProtozoan Vaccines _ximmunology
650	0	4	_aRNA, Messenger
650	0	4	_aSchistosoma mansoni _ximmunology
650	0	4	_aSchistosomiasis mansoni _ximmunology
650	0	4	_aThioglycolates _xpharmacology
650	0	4	_aTumor Necrosis Factor-alpha
650	0	4	_aVaccination
650	0	4	_aVaccines, Attenuated _ximmunology
700	1		_aCheever, A W
700	1		_aCaspar, P
700	1		_aWynn, T A
773	0		_tInfection and immunity _gvol. 66 _gno. 8 _gp. 3510-8
856	4	0	_uhttps://doi.org/10.1128/IAI.66.8.3510-3518.1998 _zAvailable from publisher's website
999			_c9639102 _d9639102